Literature DB >> 4099602

Dengue viruses from febrile patients in Nigeria, 1964-68.

D E Carey, O R Causey, S Reddy, A R Cooke.   

Abstract

Entities:  

Mesh：

Year:  1971        PMID： 4099602     DOI： 10.1016/s0140-6736(71)90840-3

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  28 in total

Review 1.  Dengue epidemiology and pathogenesis: images of the future viewed through a mirror of the past.

Authors:  Rashedul Islam; Mohammed Salahuddin; Md Salahuddin Ayubi; Tahmina Hossain; Apurba Majumder; Andrew W Taylor-Robinson; Abdullah Mahmud-Al-Rafat
Journal:  Virol Sin       Date:  2015-10-20       Impact factor: 4.327

2.  Sylvatic dengue viruses share the pathogenic potential of urban/endemic dengue viruses.

Authors:  Nikos Vasilakis; Jane Cardosa; Mawlouth Diallo; Amadou A Sall; Edward C Holmes; Kathryn A Hanley; Scott C Weaver; Javier Mota; Rebeca Rico-Hesse
Journal:  J Virol       Date:  2010-04       Impact factor: 5.103

Review 3.  Infectious diseases: annual review of significant publications.

Authors:  H A Reimann
Journal:  Postgrad Med J       Date:  1972-06       Impact factor: 2.401

4.  Epidemic ataxia in Western Nigeria.

Authors:  T S David-West
Journal:  Br Med J       Date:  1972-07-01

Review 5.  Fever from the forest: prospects for the continued emergence of sylvatic dengue virus and its impact on public health.

Authors:  Nikos Vasilakis; Jane Cardosa; Kathryn A Hanley; Edward C Holmes; Scott C Weaver
Journal:  Nat Rev Microbiol       Date:  2011-06-13       Impact factor: 60.633

Review 6.  Fever versus fever: the role of host and vector susceptibility and interspecific competition in shaping the current and future distributions of the sylvatic cycles of dengue virus and yellow fever virus.

Authors:  Kathryn A Hanley; Thomas P Monath; Scott C Weaver; Shannan L Rossi; Rebecca L Richman; Nikos Vasilakis
Journal:  Infect Genet Evol       Date:  2013-03-20       Impact factor: 3.342

7.  Emergence potential of sylvatic dengue virus type 4 in the urban transmission cycle is restrained by vaccination and homotypic immunity.

Authors:  Anna P Durbin; Sandra V Mayer; Shannan L Rossi; Irma Y Amaya-Larios; Jose Ramos-Castaneda; Eng Eong Ooi; M Jane Cardosa; Jorge L Munoz-Jordan; Robert B Tesh; William B Messer; Scott C Weaver; Nikos Vasilakis
Journal:  Virology       Date:  2013-02-26       Impact factor: 3.616

8.  Genetic and phenotypic characterization of sylvatic dengue virus type 2 strains.

Authors:  Nikos Vasilakis; Eric B Fokam; Christopher T Hanson; Ethan Weinberg; Amadou A Sall; Stephen S Whitehead; Kathryn A Hanley; Scott C Weaver
Journal:  Virology       Date:  2008-08-01       Impact factor: 3.616

Review 9.  Molecular evolution of dengue viruses: contributions of phylogenetics to understanding the history and epidemiology of the preeminent arboviral disease.

Authors:  Scott C Weaver; Nikos Vasilakis
Journal:  Infect Genet Evol       Date:  2009-02-13       Impact factor: 3.342

10.  Amplification of the sylvatic cycle of dengue virus type 2, Senegal, 1999-2000: entomologic findings and epidemiologic considerations.

Authors:  Mawlouth Diallo; Yamar Ba; Amadou A Sall; Ousmane M Diop; Jacques A Ndione; Mireille Mondo; Lang Girault; Christian Mathiot
Journal:  Emerg Infect Dis       Date:  2003-03       Impact factor: 6.883
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.